We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 26.66%
2 Healthcare 22.57%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPLK
1
DELISTED
Splunk Inc
SPLK
$174M 1.34%
873,820
+7,825
+0.9% +$1.24M
CRWD icon
2
CrowdStrike
CRWD
$218B
$170M 1.31%
6,774,964
+608,800
+10% +$12.2M
POOL icon
3
Pool Corp
POOL
$6.73B
$159M 1.23%
584,527
-27,982
-5% -$6.48M
SNPS icon
4
Synopsys
SNPS
$75.5B
$144M 1.11%
738,709
-3,400
-0.5% -$561K
WCN
5
Waste Connections
WCN
$41.5B
$138M 1.06%
1,471,284
-33,322
-2% -$2.97M
RNG icon
6
RingCentral
RNG
$6.13B
$137M 1.06%
481,023
-18,828
-4% -$4.76M
CGNX icon
7
Cognex
CGNX
$10.5B
$136M 1.05%
2,272,539
-528,835
-19% -$28.7M
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$134M 1.03%
2,410,590
+794,796
+49% +$34M
LULU icon
9
lululemon athletica
LULU
$11.1B
$129M 1%
415,022
-15,096
-4% -$3.86M
SBAC icon
10
SBA Communications
SBAC
$20.1B
$123M 0.95%
413,625
-190,503
-32% -$56.2M
TDOC icon
11
Teladoc Health
TDOC
$1.14B
$121M 0.93%
631,620
+106,187
+20% +$18.6M
TYL icon
12
Tyler Technologies
TYL
$14.9B
$118M 0.91%
340,370
MKTX icon
13
MarketAxess Holdings
MKTX
$5.75B
$113M 0.87%
224,875
-52,567
-19% -$24.5M
PEGA icon
14
Pegasystems
PEGA
$6.14B
$112M 0.87%
2,220,002
-37,300
-2% -$1.62M
GPN icon
15
Global Payments
GPN
$24.5B
$112M 0.86%
61,182
-601,300
-91% -$100M
PODD icon
16
Insulet
PODD
$10.2B
$112M 0.86%
576,458
+48,319
+9% +$9.24M
CMG icon
17
Chipotle Mexican Grill
CMG
$46.8B
$112M 0.86%
5,315,650
+146,500
+3% +$2.71M
GWW icon
18
W.W. Grainger
GWW
$62.4B
$112M 0.86%
355,406
+51,772
+17% +$15M
RBA icon
19
RB Global
RBA
$15.5B
$110M 0.85%
2,685,399
AMD icon
20
Advanced Micro Devices
AMD
$780B
$109M 0.84%
2,073,376
-593,444
-22% -$31.5M
QDEL icon
21
QuidelOrtho
QDEL
$958M
$109M 0.84%
486,896
+35,593
+8% +$5.58M
ENTG icon
22
Entegris
ENTG
$21.2B
$108M 0.83%
1,822,587
-264,326
-13% -$14.7M
INFO
23
DELISTED
IHS Markit Ltd. Common Shares
INFO
$103M 0.79%
1,360,514
-143,050
-10% -$9.74M
VEEV icon
24
Veeva Systems
VEEV
$44.5B
$101M 0.78%
429,273
+127,531
+42% +$25.3M
MSCI icon
25
MSCI
MSCI
$41.7B
$99.4M 0.77%
297,729

Similar funds

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.